A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors

NCT00678977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer, Non-Small Cell

Interventions

DRUG: Pazopanib (GW786034)
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

GlaxoSmithKline